A systematic review of the economic value proposition for commercially available nonsurgical weight-loss interventions.
Eric Andrew FinkelsteinParth A ChodavadiaKiersten StrombotnePublished in: Obesity (Silver Spring, Md.) (2023)
Evidence of cost-effectiveness for commercially available, evidence-based, nonsurgical weight-loss interventions is mixed. There is no evidence for cost-saving weight-loss medications and only weak evidence for behavioral and weight-loss interventions. Results provide a call to action to generate more robust evidence of the economic value proposition for these interventions.